Physician

Akhilesh Rao, MD

According to 2025 Medicare claims, Akhilesh Rao, MD (NPI: 1467444802) practices nephrology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is AMERICARE KIDNEY INSTITUTE LLC (NPI: 1013349471; TIN: 46-2592499) and primary practice location at 44129-5437. Rao is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 423 traditional Medicare patients, billed 1,341 HCPCS/CPT codes, and received $106,686 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 809 prescription claims across 162 beneficiaries totaling $101,159 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2015 DME data shows 24 claims. Open Payments data shows 2 records totaling $6. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,847 to $101,159. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	298	904	$69,106
2016	713	2,629	$194,213
2017	697	2,543	$184,408
2018	646	2,355	$168,415
2019	615	2,108	$166,942
2020	573	2,081	$171,516
2021	616	2,145	$168,885
2022	481	1,630	$125,691
2023	445	1,658	$127,678
2024	423	1,341	$106,686

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	31	80	$1,847
2016	43	157	$5,773
2017	105	413	$19,739
2018	145	746	$32,956
2019	162	883	$33,014
2020	149	769	$34,457
2021	162	774	$21,222
2022	177	861	$44,667
2023	171	871	$110,794
2024	162	809	$101,159

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$864
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	106	111	$132
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	45	63	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	43	50	$94
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	210	695	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	170	242	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	36	1,860	$34,971
Jardiance	Empagliflozin	15	450	$8,410
Sevelamer Carbonate	Sevelamer Carbonate	15	705	$3,188
Doxazosin Mesylate	Doxazosin Mesylate	30	2,630	$924
Calcitriol	Calcitriol	119	7,641	$880

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$6	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Akhilesh Rao, MD?

Tedicare shows public-source Medicare data for Akhilesh Rao, MD (NPI 1467444802), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akhilesh Rao, MD have ACO affiliation data?

Akhilesh Rao, MD is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Akhilesh Rao, MD?

Akhilesh Rao, MD is linked to AMERICARE KIDNEY INSTITUTE LLC (billing NPI 1013349471) in the available physician profile data.

Does Akhilesh Rao, MD have Open Payments data?

Akhilesh Rao, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.